logo
Menu
Innovation Observatory > Reports > Drugs > Benralizumab for Chronic Obstructive Pulmonary Disease (COPD)

< Back

Benralizumab for Chronic Obstructive Pulmonary Disease (COPD)

Drugs

Respiratory Disease and Thoracic Surgery

November 2017


Benralizumab is a new drug being developed for the treatment of chronic obstructive pulmonary disease. It is administered by injection under the skin and acts by targeting specific proteins that
causes the airway to narrow. If benralizumab is licensed for use in the UK, it could be a new treatment option for patients with chronic obstructive pulmonary disease that may improve quality of life and reduce the number of exacerbations.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

Benralizumab for COPD



 

Connect to the Innovation Observatory

Twitter

Load More Related Posts
Get Alerts